Issue

  • Issue: 
    1

    January, 2005

    Dear Readers,

    This first WOUNDS issue for 2005 also marks the first special section on Psychosocial Aspects in Wound Care. Our section editor, Dr. Patricia Price, has assembled 3 very interesting articles dealing with health-related quality of life (HRQoL) issues facing patients with pressure ulcers, malignant fungating ulcers, and diabetic foot ulcers. The topics presented are quite different from most of the articles we have published in the journal. I find them of great interest and of special educational value for those of us who regularly deal with quantifying wound re

  • Issue: 
    1

    I t has been my pleasure to act as a guest editor for this special edition of WOUNDS: A Compendium of Clinical Research and Practice. Those who know me personally will be aware that outcomes research, and quality of life (QoL) in particular, has been an interest of mine for a number of years. When I first started my own research in this field, health-related QoL was a relatively new concept still treated with scepticism by many. Occasionally, this is still the case, but increasingly clinicians (who, traditionally, have informally been involved in QoL outcomes for centuries) and researc

  • Issue: 
    1

    H aving a pressure ulcer (PU), particularly a stage 4 ulcer, impacts an individual’s life in overt as well as covert ways. Each individual defines this impact based on the sum of unique experiences. The elusive factor is quality of life (QoL), which can only be defined by the individual.
    Quality of life is a vague, ethereal construct that reflects an individual’s perspective on life satisfaction regardless of the situation. Quality is a term that is best described by each individual at each stage of his or her life and may change day by day or, in some cases, hour by hour. Quality of li

  • Issue: 
    1

    Disclosure: The study from which this article is drawn, Woundcare Research for Appropriate Products (WRAP), was funded by the Engineering and Physical Sciences Research Council with in-kind contributions from a number of industrial partners.

    F ungating malignant wounds are caused by tumor infiltration of the skin. Unless amenable to anti-cancer treatments, the infiltration extends, the wounds advance, and the management goals are palliative.1 The goal of palliative care is to optimize quality of life (QoL) through the control of physical symptoms and attention to individu

  • Issue: 
    1

    HEALTHPOINT Enters Licensing Agreement with Collegium for 2 Late-Stage Topical Analgesics

    Healthpoint (Fort Worth, Tex.) has entered into an agreement with Collegium Pharmaceutical, Inc. (Cumberland, RI) to license and sell 2 of Collegium’s late-stage patent-pending topical analgesics, an over the counter product and a prescription application.
    These 2 products are intended to offer clinical advantages over currently available formulations, according to the companies.
    Healthpoint researches, develops, and markets branded pharmaceuticals for surgical, tissue management, and dermatol

  • Issue: 
    1

    Disclosure: This work was funded by the MRC Health Services Research Collaboration.

    F oot ulceration is a common and costly complication of diabetes. Approximately 15% of the more than 150 million people with diabetes worldwide will develop diabetic foot ulceration at some stage in their illness.1 Through mechanisms that are not well understood, damage to the vascular and nervous systems occurs in diabetes, leading to complications. Neuropathy affecting the nerves of the feet can lead to loss of sensation, making the feet more susceptible to damage. Coupled with poor bloo

  • Issue: 
    1

    Patients and social support. Surprisingly, patients were reluctant to discuss the extent of practical and emotional support they received from family and friends, despite prompts in the interview. When support was reported, it was referred to as a general type of support rather than support specific to controlling their blood sugar or healing their ulcers.
    Interviewer: “Do you find that your family [is] very supportive?”
    Patient: “Oh, yeah, yeah.”
    Interviewer: “And do they help with your diabetes and your foot problems specifically, or is it a more general kind of sup

Ostomy Wound Management

Press Release

ConvaTec and Boehringer Technologies Announce License Agreement


ConvaTec Acquires Exclusive Worldwide Rights for a Negative Pressure Wound Therapy System

SKILLMAN, NJ (December 18, 2008) — ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced today it has signed a long-term global exclusive license agreement with Boehringer Technologies to market and distribute Boehringer’s Engenex® Negative Pressure Wound Therapy (NPWT) System incorporating Bio-Dome™ Interface Technology.


WOUNDS News Wire

CME Showcase

"Diabetic Peripheral Neuropathy"

Upcoming Accredited Webcast

Release Date: December 22, 2008

Expiration Date: December 22, 2009

This activity is supported by an educational grant from PamLabs.
This activity is sponsored by the North American Center For Continuing Medical Education (NACCME).

To register for this Webcast, visit www.naccme.com/program/n-558/


"Current Concepts In Healing Chronic Diabetic Foot Ulcerations"

Upcoming Live Accredited Webcast with Q&A Noon to 1 p.m. EDT January 20, 2009

Rebroadcasts

7:30-8:30 p.m. EDT
January 27, 2009

3-4 p.m. EDT
January 28, 2009

This activity is supported by an educational grant from Advanced Biohealing.
This activity is sponsored by the North American Center For Continuing Medical Education (NACCME).

To register for this Webcast, visit www.naccme.com/program/n-550/


MRSA And Diabetic Foot Wounds: Where Do We Go From Here?
Accredited Webcast Archive Version available now. This activity is supported by an educational grant from Pfizer. This activity is sponsored by the North American Center For Continuing Medical Education (NACCME).

 

PERIPHERAL ARTERIAL DISEASE (PAD) AND CRITICAL LIMB ISCHEMIA (CLI): Managing Vascular and Wound Healing Challenges with Current and Emerging Technologies
Archived Accredited Webcast with Q&A:
This activity is supported by an educational grant from Baxter Healthcare Corporation.


Maintenance Debridement: A New Look at Science and Art
Accredited Webcast with Q&A:
November 17, 2008 at 3:00pm EST
This activity is supported by an educational grant from HealthPoint Ltd.
 

REVIEW OUR OTHER
WOUND CARE BRANDS

Check out our other resources for healthcare professionals of all specialties.

  • Ostomy Wound Management
  • Todays Wound Clinic
  • Podiatry Today
  • Skin and Aging